Updates on Management of Gastric Cancer.
PURPOSE OF REVIEW
Gastric adenocarcinoma is the fifth most common and the third most lethal cancer worldwide. Surgery is the only chance of cure, but recurrence is common, even with complete resection.


RECENT FINDINGS
Advances in diagnosis and staging, genomic classification, surgical resection and treatment of peritoneal disease, systemic chemotherapy and chemoradiation, and targeted and immune therapies have led to the current multidisciplinary approach to gastric adenocarcinoma. Treatment of gastric cancer is rapidly evolving in an effort to combat this challenging disease.
['Johnston|Fabian M|FM|', 'Beckman|Michael|M|']
D000230:Adenocarcinoma D000971:Antineoplastic Combined Chemotherapy Protocols D014408:Biomarkers, Tumor D059248:Chemoradiotherapy D017024:Chemotherapy, Adjuvant D013502:General Surgery D006801:Humans D007167:Immunotherapy D058990:Molecular Targeted Therapy D013274:Stomach Neoplasms
Gastric cancer Gastric adenocarcinoma CYTO-CHIP FLOT HIPEC Siewert type III